November 2020 – Fairview, PA – X-Cell Tool & Mold, Inc. of Fairview, PA has been acquired by SyBridge Technologies of Southfield, MI. X-Cell is a leading manufacturer of close-tolerance and multi-cavity plastic injection molds primarily for the medical industry while also serving the consumer goods and electronics industries. The company was founded in 1996 and utilizes state of the art engineering and manufacturing capabilities to provide precise and effective customer tooling.
SyBridge Technologies is a global technological leader in the tooling and mold industry. This transaction marks the first acquisition by SyBridge in the medical tooling industry and supplements its leading presence in the mobility end market through its Concours Technologies subsidiary. As a part of SyBridge, X-Cell will be able to leverage design, engineering, supply chain, and production capabilities to better serve and grow with its customers.
“X-Cell is a strong beginning to SyBridge building a leading franchise in the medial tooling industry,” said Tony Nardone, CEO of SyBridge. “Through continuing to grow with new and existing customers and targeted acquisitions which will complement X-Cell, we are highly optimistic about our growth prospects within the medical industry.”
SyBridge is a portfolio company of Crestview Partners. Crestview is a value-oriented private equity firm focused on the middle market. The firm is based in New York and manages funds with over $9 billion of aggregate capital commitments. The firm is led by a group of partners who have complementary experience and distinguished backgrounds in private equity, finance, operations, and management.
MBS Advisors represented SyBridge Technologies in the transaction.
Excerpts from above were taken from a press release written by SyBridge Technologies. For the full press release, click here.